• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS / RESPIRONICS, INC. DREAMSTATION CPAP; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS / RESPIRONICS, INC. DREAMSTATION CPAP; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Model Number DSX500T11C
Device Problem Use of Device Problem (1670)
Patient Problems Dyspnea (1816); Fatigue (1849); Nausea (1970); Dizziness (2194); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Event Description
Began using philips dreamstation cpap in 2018.Diagnosed with stage 5 kidney disease in (b)(6) 2019.Has breathing problems, fatigue, lightheadedness, shortness of breath and nausea as a result of cpap usage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DREAMSTATION CPAP
Type of Device
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
PHILIPS / RESPIRONICS, INC.
MDR Report Key17282115
MDR Text Key318658961
Report NumberMW5119199
Device Sequence Number1
Product Code BZD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 06/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/06/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberDSX500T11C
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
APRESOLINE; ARANESP; ASPIRIN ; CARDURA; COREG; DEMADEX; FLONASE; KENALOG; NORVASC; OZEMPIC ; PRAVACHOL; PROTONIX; RANVELA; REVATIO; SILVADENE; ZYLOPRIM
Patient Outcome(s) Disability; Required Intervention; Life Threatening;
Patient Age65 YR
Patient SexMale
Patient Weight128 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-